Loading data
AXGNNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 225.21 m USD | 187.34 m USD | 159.01 m USD | 138.58 m USD | 127.36 m USD |
| Cost of revenue | 57.86 m USD | 45.36 m USD | 37.14 m USD | 29.78 m USD | 22.93 m USD |
| Gross profit | 167.35 m USD | 141.98 m USD | 121.87 m USD | 108.81 m USD | 104.43 m USD |
| Research and development expense | 32.89 m USD | 27.77 m USD | 27.34 m USD | 25.63 m USD | 24.18 m USD |
| Operating profit | -7.85 m USD | -3.29 m USD | -21.46 m USD | -29.71 m USD | -25.42 m USD |
| Interest expense | — | — | 2.84 m USD | 624 k USD | 1.36 m USD |
| Income tax expense | 0 USD | — | — | — | — |
| Net income (reported basis) | -15.7 m USD | -9.96 m USD | -21.72 m USD | -28.95 m USD | -26.99 m USD |
| Basic earnings per share | -0.34 USD/share | -0.23 USD/share | -0.51 USD/share | -0.69 USD/share | -0.65 USD/share |
| Diluted earnings per share | -0.34 USD/share | -0.23 USD/share | -0.51 USD/share | -0.69 USD/share | -0.65 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.